IL163753A0 - Non-nucleoside reverse transcriptase inhibitors - Google Patents

Non-nucleoside reverse transcriptase inhibitors

Info

Publication number
IL163753A0
IL163753A0 IL16375303A IL16375303A IL163753A0 IL 163753 A0 IL163753 A0 IL 163753A0 IL 16375303 A IL16375303 A IL 16375303A IL 16375303 A IL16375303 A IL 16375303A IL 163753 A0 IL163753 A0 IL 163753A0
Authority
IL
Israel
Prior art keywords
reverse transcriptase
transcriptase inhibitors
nucleoside reverse
nucleoside
inhibitors
Prior art date
Application number
IL16375303A
Other languages
English (en)
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of IL163753A0 publication Critical patent/IL163753A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL16375303A 2002-05-16 2003-05-14 Non-nucleoside reverse transcriptase inhibitors IL163753A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38088602P 2002-05-16 2002-05-16
PCT/CA2003/000718 WO2003097644A2 (en) 2002-05-16 2003-05-14 Non-nucleoside reverse transcriptase inhibitors

Publications (1)

Publication Number Publication Date
IL163753A0 true IL163753A0 (en) 2005-12-18

Family

ID=29550032

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16375303A IL163753A0 (en) 2002-05-16 2003-05-14 Non-nucleoside reverse transcriptase inhibitors

Country Status (29)

Country Link
US (1) US6806265B2 (de)
EP (1) EP1506195B1 (de)
JP (1) JP4230448B2 (de)
KR (1) KR20050008716A (de)
CN (1) CN1318421C (de)
AR (1) AR040027A1 (de)
AT (1) ATE412653T1 (de)
AU (1) AU2003229186A1 (de)
BR (1) BR0310033A (de)
CA (1) CA2485916C (de)
DE (1) DE60324418D1 (de)
EA (1) EA009178B1 (de)
EC (1) ECSP045432A (de)
ES (1) ES2315492T3 (de)
HK (1) HK1080849A1 (de)
HR (1) HRP20041065A2 (de)
IL (1) IL163753A0 (de)
MX (1) MXPA04010409A (de)
MY (1) MY134646A (de)
NO (1) NO20044104L (de)
NZ (1) NZ536736A (de)
PE (1) PE20040365A1 (de)
PL (1) PL371663A1 (de)
RS (1) RS98004A (de)
TW (1) TW200404071A (de)
UA (1) UA79285C2 (de)
UY (1) UY27809A1 (de)
WO (1) WO2003097644A2 (de)
ZA (1) ZA200406912B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004087169A1 (en) * 2003-03-27 2004-10-14 Boehringer Ingelheim International Gmbh Antiviral combination of nevirapine and a further antiretroviral compound
US7348338B2 (en) 2003-07-17 2008-03-25 Plexxikon, Inc. PPAR active compounds
AU2004259738B2 (en) * 2003-07-17 2011-11-17 Plexxikon, Inc. PPAR active compounds
DE102004051277A1 (de) * 2004-10-21 2006-04-27 Merck Patent Gmbh Heterocyclische Carbonylverbindungen
EP1819673A2 (de) * 2004-11-30 2007-08-22 Plexxikon, Inc. Indolderivate zur verwendung als ppar-aktive verbindungen
US20070072904A1 (en) * 2005-09-07 2007-03-29 Jack Lin PPAR active compounds
RU2008108221A (ru) * 2005-09-07 2009-10-20 Плекссикон, Инк. (Us) Соединения, активные в отношении ppar (рецепторов активаторов пролиферации пероксисом)
AU2006287528A1 (en) * 2005-09-07 2007-03-15 Plexxikon, Inc. 1 , 4 and 1 , 5-disubstituted indole derivatives for use as PPAR active compounds
WO2008051197A2 (en) 2005-09-20 2008-05-02 Mayo Foundation For Medical Education And Research Small-molecule botulinum toxin inhibitors
PE20090159A1 (es) * 2007-03-08 2009-02-21 Plexxikon Inc COMPUESTOS DERIVADOS DE ACIDO INDOL-PROPIONICO COMO MODULADORES PPARs
US10047096B2 (en) 2014-11-25 2018-08-14 Bayer Pharma Aktiengesellschaft Substituted pyridobenzodiazepinone-derivatives and use thereof
US11299467B2 (en) 2017-07-21 2022-04-12 Antabio Sas Chemical compounds
HRP20220331T1 (hr) 2018-03-08 2022-05-13 Incyte Corporation Spojevi aminopirazin diola kao inhibitori pi3k-y
US11046658B2 (en) 2018-07-02 2021-06-29 Incyte Corporation Aminopyrazine derivatives as PI3K-γ inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366972A (en) 1989-04-20 1994-11-22 Boehringer Ingelheim Pharmaceuticals, Inc. 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection
US5705499A (en) * 1995-10-06 1998-01-06 Boehringer Ingelheim Pharmaceuticals, Inc. 8-arylalkyl- and 8-arylheteroalkyl-5,11-dihydro-6H-dipyrido 3,2-B:2',3'-e! 1!diazepines and their use in the treatment of HIV-1 infection
TWI270547B (en) 2000-06-16 2007-01-11 Boehringer Ingelheim Ca Ltd Non-nucleoside reverse transcriptase inhibitors
US6716836B2 (en) 2001-03-22 2004-04-06 Boehringer Ingelheim (Canada) Ltd. Non-nucleoside reverse transcriptase inhibitors
US6673791B2 (en) 2001-07-30 2004-01-06 Boehringer Ingelheim (Canada) Ltd. Non-nucleoside reverse transcriptase inhibitors

Also Published As

Publication number Publication date
BR0310033A (pt) 2005-02-15
CA2485916C (en) 2009-12-08
WO2003097644A3 (en) 2004-02-05
KR20050008716A (ko) 2005-01-21
EA009178B1 (ru) 2007-12-28
UA79285C2 (en) 2007-06-11
PL371663A1 (en) 2005-06-27
US20040006071A1 (en) 2004-01-08
UY27809A1 (es) 2003-12-31
NO20044104L (no) 2004-12-01
MY134646A (en) 2007-12-31
CN1318421C (zh) 2007-05-30
EA200401482A1 (ru) 2005-06-30
ZA200406912B (en) 2006-06-28
JP4230448B2 (ja) 2009-02-25
PE20040365A1 (es) 2004-07-22
CA2485916A1 (en) 2003-11-27
ATE412653T1 (de) 2008-11-15
HK1080849A1 (en) 2006-05-04
ES2315492T3 (es) 2009-04-01
CN1653066A (zh) 2005-08-10
TW200404071A (en) 2004-03-16
US6806265B2 (en) 2004-10-19
WO2003097644A2 (en) 2003-11-27
ECSP045432A (es) 2005-01-03
EP1506195A2 (de) 2005-02-16
AU2003229186A1 (en) 2003-12-02
HRP20041065A2 (en) 2005-04-30
NZ536736A (en) 2006-11-30
DE60324418D1 (de) 2008-12-11
MXPA04010409A (es) 2005-02-17
JP2005526851A (ja) 2005-09-08
AR040027A1 (es) 2005-03-09
RS98004A (en) 2006-12-15
EP1506195B1 (de) 2008-10-29

Similar Documents

Publication Publication Date Title
HK1080849A1 (en) Non-nucleoside reverse transcriptase inhibitors
PL378556A1 (pl) Nienukleozydowe inhibitory odwrotnej transkryptazy
TWI372619B (en) Non-nucleoside reverse transcriptase inhibitors
AU2003269628A1 (en) Non-nucleoside reverse transcriptase inhibitors
EG25482A (en) Inhibitors
PL373649A1 (en) Kinase inhibitors
SI1569907T1 (sl) Na nikotinamidu osnovani kinazni inhibitorji
IL144349A0 (en) Non-nucleoside reverse transcriptase inhibitors
HK1111155A1 (en) Non-nucleoside reverse transcriptase inhibitors
EP1558609A4 (de) Kinase-hemmer
EP1532133A4 (de) Nf-:b-inhibitoren
IL152819A0 (en) Non-nucleoside reverse transcriptase inhibitors
EP1569907A4 (de) Nicotinamid-basierte kinasehemmer
EP1899340A4 (de) Nicht-nukleosidische reverse-transkriptase-hemmer
HRP20040886A2 (en) Non-nucleoside reverse transcriptase inhibitors
EP1326640A4 (de) Nichtnucleosidischer reverse-transcriptase-hemmer als antiretrovirale therapie
AU2002355614A1 (en) Non-nucleoside reverse transcriptase inhibitors
SI1294720T1 (sl) Nenukleozidni inhibitorji reverzne transkriptaze
DK1373267T3 (da) Non-nucleoside revers transkriptase-inhibitorer
GB0207491D0 (en) Inhibitors
GB0208094D0 (en) Inhibitors
GB0224102D0 (en) Inhibitors
GB0226149D0 (en) Inhibitors
GB0217330D0 (en) Inhibitors
GB0206031D0 (en) Inhibitors